BIO

Noor Jailkhani, PhD, is a scientist-entrepreneur and the CEO and co-founder of Matrisome Bio, a biotech company developing first-in-class targeted therapies for cancer and fibrosis by leveraging the extracellular matrix (ECM). As the founding CEO, Noor has led the company since its inception, successfully securing seed funding from venture investors and steering the company’s strategic vision. She is driven by a commitment to patient-centered biotech innovation, drawing on her experiences as a scientist, entrepreneur, and caregiver to bridge scientific discovery with clinical impact.

Noor brings over a decade of technical experience in oncology and ECM biology, with a focus on developing ECM-targeted agents for cancer detection and therapy. Her research has led to multiple publications and patent applications in cancer, ECM biology, and their therapeutic applications. She is currently building Matrisome Bio’s team at LabCentral, leveraging her expertise to advance ECM-targeted therapies to the clinic.

Prior to founding Matrisome Bio, she was a research scientist at MIT’s Koch Institute for Integrative Cancer Research, where she played a pivotal role in developing the company’s foundational technology. Noor earned her PhD in Immunology from the International Centre for Genetic Engineering and Biotechnology (ICGEB) and completed her postdoctoral training at MIT as a Mazumdar-Shaw International Oncology Fellow.